ENS vs. CVS
ENS (EnerSys) and CVS (CVS Health Corporation) are both stocks. ENS operates in Electrical Equipment & Parts (Industrials), while CVS operates in Healthcare Plans (Healthcare). Over the past 10 years, ENS returned 14.64%/yr vs 2.96%/yr for CVS. At a 0.32 correlation, their price movements are largely independent.
Performance
ENS vs. CVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENS achieves a 62.69% return, which is significantly higher than CVS's 21.52% return. Over the past 10 years, ENS has outperformed CVS with an annualized return of 14.64%, while CVS has yielded a comparatively lower 2.96% annualized return.
ENS
- 1D
- -0.75%
- 1M
- 8.12%
- YTD
- 62.69%
- 6M
- 63.26%
- 1Y
- 181.23%
- 3Y*
- 33.98%
- 5Y*
- 20.88%
- 10Y*
- 14.64%
CVS
- 1D
- 3.78%
- 1M
- 17.51%
- YTD
- 21.52%
- 6M
- 25.65%
- 1Y
- 54.61%
- 3Y*
- 14.62%
- 5Y*
- 5.29%
- 10Y*
- 2.96%
ENS vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENS EnerSys | 62.69% | 60.28% | -7.57% | 37.90% | -5.64% | -4.04% | 12.19% | -2.57% | 12.46% | -9.97% |
CVS CVS Health Corporation | 21.52% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -7.04% | -5.75% |
Correlation
The correlation between ENS and CVS is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2004 | 0.32 |
The correlation between ENS and CVS shifts across timeframes, from 0.13 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ENS:
$9.09B
CVS:
$121.27B
ENS:
$7.67
CVS:
$2.30
ENS:
31.08
CVS:
41.19
ENS:
2.43
CVS:
0.30
ENS:
4.77
CVS:
1.57
ENS:
$3.75B
CVS:
$407.91B
ENS:
$1.10B
CVS:
$56.59B
ENS:
$426.46M
CVS:
$9.99B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENS vs. CVS — Risk / Return Rank
ENS
CVS
ENS vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EnerSys (ENS) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENS | CVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.21 | ||
| Sortino ratioReturn per unit of downside risk | +2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.70 | 1.33 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 9.96 | 3.34 | +6.62 |
| Martin ratioReturn relative to average drawdown | 36.14 | 8.59 | +27.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENS | CVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.98 | 1.77 | +3.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.61 | 0.18 | +0.43 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.10 | +0.30 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.33 | +0.03 |
Drawdowns
ENS vs. CVS - Drawdown Comparison
The maximum ENS drawdown since its inception was -83.95%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for ENS and CVS.
Loading charts...
Drawdown Indicators
| ENS | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.95% | -64.07% | -19.88% |
Max Drawdown (1Y)Largest decline over 1 year | -18.32% | -16.44% | -1.88% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -43.98% | +14.66% |
Max Drawdown (5Y)Largest decline over 5 years | -41.77% | -56.79% | +15.02% |
Max Drawdown (10Y)Largest decline over 10 years | -56.27% | -56.79% | +0.52% |
Current DrawdownCurrent decline from peak | -2.05% | -3.35% | +1.30% |
Average DrawdownAverage peak-to-trough decline | -18.01% | -19.55% | +1.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.04% | 6.37% | -1.33% |
Volatility
ENS vs. CVS - Volatility Comparison
EnerSys (ENS) has a higher volatility of 16.42% compared to CVS Health Corporation (CVS) at 11.22%. This indicates that ENS's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENS | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.42% | 11.22% | +5.20% |
Volatility (6M)Calculated over the trailing 6-month period | 31.38% | 26.20% | +5.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.62% | 31.00% | +5.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.51% | 29.96% | +4.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.66% | 29.29% | +7.37% |
Dividends
ENS vs. CVS - Dividend Comparison
ENS's dividend yield for the trailing twelve months is around 0.43%, less than CVS's 2.81% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVS CVS Health Corporation | 2.81% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
ENS EnerSys | 0.43% | 0.68% | 1.01% | 0.79% | 0.95% | 0.89% | 0.84% | 0.94% | 0.90% | 1.01% | 0.90% | 1.25% |
Financials
ENS vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between EnerSys and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ENS vs. CVS - Profitability Comparison
ENS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EnerSys reported a gross profit of 290.86M and revenue of 988.01M. Therefore, the gross margin over that period was 29.4%.
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.
ENS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EnerSys reported an operating income of 123.75M and revenue of 988.01M, resulting in an operating margin of 12.5%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.
ENS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EnerSys reported a net income of 77.20M and revenue of 988.01M, resulting in a net margin of 7.8%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.
Frequently Asked Questions
ENS and CVS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENS has higher volatility (16.42%) compared to CVS (11.22%). In terms of maximum drawdown, ENS dropped -83.95% vs CVS's -64.07%.
ENS currently has the higher Sharpe Ratio (4.98 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENS and CVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer